Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528040) titled 'An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection' on April 7.
Study Type: Observational
Primary Sponsor: Shanghai 10th People's Hospital
Condition:
Crohn's Disease (CD)
Intervention:
Drug: Guselkumab
Recruitment Status: Not recruiting
Date of First Enrollment: April 15, 2026
Target Sample Size: 88
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07528040
Published by HT Digital Content Services with permission from Health Daily Digest....